Antibody–drug conjugates have emerged as a powerful tool ... This is a multifaceted process, says Peterson, “with many moving parts that each require exploration and optimization”.

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on ...

Scientists from the National Institutes for Food and Drug Control have characterized antibody-drug conjugates (ADCs) using ...

The theory behind antibody drug conjugates (ADCs ... An increasing demand for ADC development and manufacturing capabilities With almost 90% of 2022 ADC revenues generated by substantial players ...

New kits are designed to offer a convenient method to label any antibody with one of Bio-Rad’s StarBright Dyes.

The development of new, safe, and effective drugs for ... Once the trial process is complete and regulatory approval has been granted, an antibody therapeutic can enter the manufacturing stage ...

Antibody-RNA Conjugates represent a significant advancement in the treatment of challenging and rare diseases with unmet medical need.

Samsung Biologics has extended its collaboration with LigaChem Biosciences for antibody-drug conjugate (ADC ... supports the development and manufacturing process of ADC therapies, from late ...

Extension of long-term collaboration includes construction of new customer-dedicated bioconjugation capacity in Visp (CH) and commercial antibody ... ADC manufacturing, from early development stages ...

Co., Ltd. (“MediLink”) to use MediLink’s TMALIN ® antibody-drug conjugate (ADC) platform for the development of a novel LRRC15 ADC, ZL-6201, consisting of an antibody discovered by Zai Lab.

Exclusive global license outside of Greater Chinafor MRG007, a novel antibody drug conjugate (ADC) in development for gastrointestinal (GI) cancers First Investigational New Drug (IND) submission ...